Reduced Stroke Outcome Results - Momentum 3 Clinical Trial
https://www.thoratec.com/

Reduced Stroke Outcome Results - Momentum 3 Clinical Trial

Carlos Rapallo, MD. MTSAC

Head of Cardiology Division at Sanatorio Anchorena Itoiz. Professor of Cardiology at USAL|University of Buenos Aires. Advanced Cardiac Imaging Specialist at ICBA & San Fernando Hospital

6 年

Great advance in Mechanical Circulatory Support. The investigators founded that, at 2 years, the centrifugal-flow pump was superior to the axial-flow pump with respect to a composite primary end point of survival free of disabling stroke or reoperation to replace or remove a malfunctioning device. The Heartmate II is on retired?

要查看或添加评论,请登录

Stacy Arnold的更多文章